Literature DB >> 15499116

The PROGRESS trial three years later: time for a balanced report of effectiveness.

Richard Wennberg1, Camilla Zimmermann.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15499116      PMCID: PMC524114          DOI: 10.1136/bmj.329.7472.968

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  17 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  The lowering of blood pressure after stroke.

Authors:  C Cates
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

3.  Blood-pressure lowering for the secondary prevention of stroke.

Authors:  J A Staessen; J Wang
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

4.  Does lowering blood pressure prevent recurrent stroke?

Authors:  Andrew M Tonkin
Journal:  Med J Aust       Date:  2002-03-18       Impact factor: 7.738

5.  The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.

Authors:  Bruce M Psaty; Noel S Weiss; Curt D Furberg
Journal:  Am J Hypertens       Date:  2002-05       Impact factor: 2.689

6.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

Review 7.  Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.

Authors:  G Jackson
Journal:  Int J Clin Pract       Date:  2003-06       Impact factor: 2.503

Review 8.  [Control of arterial hypertension in stroke prevention].

Authors:  A N Britov; M M Bystrova; A A Orlov
Journal:  Klin Med (Mosk)       Date:  2002

9.  Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.

Authors: 
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

10.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Authors:  Fiona Turnbull
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321

View more
  13 in total

1.  The PROGRESS trial three years later: time for more action, less distraction.

Authors:  Stephen Macmahon; Bruce Neal; Anthony Rodgers; John Chalmers
Journal:  BMJ       Date:  2004-10-23

2.  Trial protocols: time for more than tinkering.

Authors:  James Penston
Journal:  BMJ       Date:  2005-02-19

3.  The PROGRESS trial three years later: evangelism is understandable.

Authors:  Peter Ward
Journal:  BMJ       Date:  2004-12-11

4.  The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed.

Authors:  Daniel G Hackam
Journal:  BMJ       Date:  2004-12-11

5.  The PROGRESS trial three years later: all aspects of secondary prevention after stroke need to be improved.

Authors:  Helen Rodgers
Journal:  BMJ       Date:  2004-12-11

6.  The PROGRESS trial three years later: HOPE trial may shed some light.

Authors:  John Attia; Catherine D'Este; Christopher R Levi
Journal:  BMJ       Date:  2004-12-11

7.  Perindopril monotherapy and PROGRESS in Europe.

Authors:  Richard Wennberg; Camilla Zimmermann
Journal:  BMJ       Date:  2005-07-23

8.  Users' guide to detecting misleading claims in research: misleading claims may be symptom of even more serious flaws.

Authors:  James Penston
Journal:  BMJ       Date:  2005-01-15

Review 9.  Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy.

Authors:  Andrea Lippoldt; Andreas Reichel; Ursula Moenning
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

10.  Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis.

Authors:  Shaheen E Lakhan; Michael T Sapko
Journal:  Int Arch Med       Date:  2009-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.